GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
203 hedge funds and large institutions have $2.4B invested in Global Blood Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 78 increasing their positions, 62 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% less call options, than puts
Call options by funds: $13.9M | Put options by funds: $14M
1% less funds holding
Funds holding: 205 → 203 (-2)
Holders
203
Holding in Top 10
10
Calls
$13.9M
Puts
$14M
Top Buyers
| 1 | +$54.6M | |
| 2 | +$25.5M | |
| 3 | +$20.6M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$17.3M |
| 5 |
PA
Perceptive Advisors
New York
|
+$15.3M |
Top Sellers
| 1 | -$42.7M | |
| 2 | -$25.2M | |
| 3 | -$11.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.61M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$4.72M |